NanJing Pharmaceutical Co Ltd (600713) — Cash Flow-to-Debt Ratio
NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-942.93 Million could theoretically repay 0% of its total liabilities (CN¥26.09 Billion) in one year. See how much free cash does NanJing Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NanJing Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for NanJing Pharmaceutical Co Ltd across 27 annual periods. Also explore net asset momentum of NanJing Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NanJing Pharmaceutical Co Ltd (1998–2024)
Year-by-year debt coverage analysis for NanJing Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is NanJing Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +3.6% |
| 2023 | 0.09x | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +429.6% |
| 2022 | -0.03x | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -181.2% |
| 2021 | 0.03x | CN¥695.33 Million | CN¥20.65 Billion | ▲ +154.3% |
| 2020 | -0.06x | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -207.7% |
| 2019 | 0.06x | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +342.3% |
| 2018 | -0.02x | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -194.6% |
| 2017 | 0.03x | CN¥319.99 Million | CN¥12.74 Billion | ▲ +213.6% |
| 2016 | -0.02x | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +28.4% |
| 2015 | -0.03x | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +19.1% |
| 2014 | -0.04x | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +9.8% |
| 2013 | -0.04x | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -299.4% |
| 2012 | 0.02x | CN¥168.17 Million | CN¥7.91 Billion | ▲ +123.5% |
| 2011 | -0.09x | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -639.4% |
| 2010 | 0.02x | CN¥119.08 Million | CN¥7.11 Billion | ▲ +378.2% |
| 2009 | 0.00x | CN¥20.22 Million | CN¥5.77 Billion | ▲ +258.8% |
| 2008 | 0.00x | CN¥4.33 Million | CN¥4.43 Billion | ▼ -94.8% |
| 2007 | 0.02x | CN¥81.08 Million | CN¥4.30 Billion | ▼ -64.4% |
| 2006 | 0.05x | CN¥161.31 Million | CN¥3.04 Billion | ▼ -14.1% |
| 2005 | 0.06x | CN¥165.57 Million | CN¥2.68 Billion | ▲ +856.7% |
| 2004 | 0.01x | CN¥16.26 Million | CN¥2.52 Billion | ▼ -32.4% |
| 2003 | 0.01x | CN¥19.27 Million | CN¥2.02 Billion | ▼ -81.8% |
| 2002 | 0.05x | CN¥68.75 Million | CN¥1.31 Billion | ▲ +970.8% |
| 2001 | -0.01x | CN¥-4.20 Million | CN¥697.93 Million | ▼ -105.1% |
| 2000 | 0.12x | CN¥87.68 Million | CN¥742.31 Million | ▲ +17.1% |
| 1999 | 0.10x | CN¥50.58 Million | CN¥501.56 Million | ▼ -42.7% |
| 1998 | 0.18x | CN¥77.45 Million | CN¥440.31 Million | — |